JAZZ vs MERC · P/E 1988, rev $2.28B vs rev $949.6M
Jazz Pharmaceuticals PLC (JAZZ) versus Mercer International Inc (MERC) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Mercer International Inc (MERC) is a paper & paper products company listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported MERC revenue for 2026-06-30 was $949.6M. Net income was -$128.0M. Revenue was up 94.1% from 2026-03-31 to 2026-06-30. MERC currently screens at market cap $59.2M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. MERC currently screens at market cap $59.2M.
Not investment advice. Open the JAZZ and MERC stock pages for the full models.
Not investment advice.